# Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin

> **NCT01139320** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 300 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** polymerase chain reaction
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT01139320
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2016-05
- **Final completion:** —
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01139320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01139320, "Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01139320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*